16:17 , May 3, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Melanoma Mouse studies suggest the PPARγ agonist Avandia rosiglitazone could help treat melanoma. In a mouse model of melanoma, Avandia plus an irradiated GM-CSF-secreting tumor cell vaccine and an anti-CTLA-4 mAb decreased tumor incidence...
18:30 , Apr 20, 2018 |  Clinical Results  |  Clinical Results

BriaCell's Bria-IMT leads to tumor regressions in Phase I/IIa for breast cancer

BriaCell Therapeutics Corp. (TSX-V:BCT; OTCQB:BCTXF) reported data from six patients with stage IV breast cancer in the Phase I/IIa WRI-GEV-007 trial showing that Bria-IMT (SV-BR-1-GM) led to tumor regression in two patients, including one with...
20:15 , Feb 16, 2017 |  BC Week In Review  |  Clinical News

BriaVax: Ph I/IIa start

This quarter, BriaCell will begin an open-label, U.S. Phase I/IIa trial to evaluate intradermal BriaVax comprising 20×10 6 cells given every 2 weeks for the first month and then monthly for up to 1 year...
07:00 , Sep 5, 2016 |  BC Week In Review  |  Financial News

BriaCell completes private placement of units

BriaCell Therapeutics Corp. (TSX-V:BCT; OTCQB:ANCCF), Berkeley, Calif.   Business: Cancer   Date completed: 2016-08-19   Type: Private placement of units   Raised: C$1.7 million ($1.3 million)   Units: 8.5 million   Price: C$0.20   Shares...
07:00 , May 9, 2016 |  BC Week In Review  |  Financial News

BriaCell completes private placement of units

BriaCell Therapeutics Corp. (TSX-V:BCT; OTCQB:ANCCF), Los Angeles, Calif.   Business: Cancer   Date completed: 2016-05-03   Type: Private placement of units   Raised: C$650,000 ($517,790)   Price: C$0.19 (unit)   Shares outstanding prior: 84.7 million...
07:00 , May 9, 2016 |  BC Week In Review  |  Financial News

BriaCell completes private placement of units

BriaCell Therapeutics Corp. (TSX-V:BCT; OTCQB:ANCCF), Los Angeles, Calif.   Business: Cancer   Date completed: 2016-05-03   Type: Private placement of units   Raised: C$625,000 ($497,875)   Price: C$0.20 (unit)   Shares outstanding prior: 84.7 million...
01:01 , Jun 17, 2015 |  BC Extra  |  Company News

Management tracks

The Pharmaceutical Research and Manufacturers of America (PhRMA) elected five new board members. They are Werner Baumann, chairman of the board of management at the Bayer HealthCare AG subsidiary of Bayer AG (Xetra:BAYN); Giovanni Caforio,...